Aviva’s Balchem Corp BCPC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$304K Buy
1,800
+78
+5% +$13K ﹤0.01% 832
2026
Q1
$292K Sell
1,722
-385
-18% -$65.4K ﹤0.01% 828
2025
Q4
$323K Buy
+2,107
New +$322K ﹤0.01% 850
2023
Q4
Sell
-4,533
Closed -$562K 1031
2023
Q3
$562K Sell
4,533
-6,302
-58% -$838K ﹤0.01% 858
2023
Q2
$1.46M Sell
10,835
-486
-4% -$62.5K 0.01% 726
2023
Q1
$1.43M Buy
11,321
+3,718
+49% +$481K 0.01% 788
2022
Q4
$928K Sell
7,603
-4,409
-37% -$582K ﹤0.01% 903
2022
Q3
$1.46M Sell
12,012
-4,484
-27% -$584K 0.01% 832
2022
Q2
$2.14M Buy
16,496
+288
+2% +$36K 0.01% 765
2022
Q1
$2.22M Buy
16,208
+552
+4% +$79.1K 0.01% 803
2021
Q4
$2.64M Buy
15,656
+3,452
+28% +$554K 0.01% 749
2021
Q3
$1.77M Buy
+12,204
New +$1.65M 0.01% 775
2021
Q2
Sell
-9,526
Closed -$1.2M 989
2021
Q1
$1.2M Sell
9,526
-3,653
-28% -$444K 0.01% 857
2020
Q4
$1.52M Sell
13,179
-10,686
-45% -$1.13M 0.01% 758
2020
Q3
$2.33M Sell
23,865
-346
-1% -$33.9K 0.01% 667
2020
Q2
$2.3M Sell
24,211
-13,487
-36% -$1.26M 0.01% 695
2020
Q1
$3.72M Buy
37,698
+18,758
+99% +$1.92M 0.03% 527
2019
Q4
$1.93M Buy
+18,940
New +$1.91M 0.01% 757

Other funds holding BCPC

Aviva's BCPC Position: Q2 2026 in Review

Aviva increased its Balchem Corp (BCPC) stake by 4.5% in Q2 2026, buying an estimated $13K and bringing the position to 1,800 shares worth $304K. The position accounts for ﹤0.01% of the portfolio, ranked #832.

Aviva first reported a position in BCPC in Q4 2019 and has held it in 18 quarters since. The position peaked at $3.72M in Q1 2020. 417 funds tracked by Wall St. Rank hold BCPC as of Q2 2026.

  • Aviva held 1,800 shares of Balchem Corp worth $304K as of Q2 2026.
  • Aviva bought 78 Balchem Corp shares in Q2 2026, an estimated $13K.
  • Balchem Corp made up ﹤0.01% of Aviva's portfolio in Q2 2026, its #832 holding.
  • Aviva first reported a position in Balchem Corp in Q4 2019 and has held it in 18 quarters since.
  • Aviva's Balchem Corp position peaked at $3.72M in Q1 2020.
  • 417 funds tracked by Wall St. Rank held Balchem Corp as of Q2 2026.

Based on Aviva's 13F filing for Q2 2026, filed 13 Aug 2026.